Kaseta Michael — SEC insider filings

SEC reporting owner CIK 1724346. 49 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers all 49 filings on record, filed 2020-12-01 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Liquidia Corp (LQDA)CFO and COO424 legs · 28,627 sh · $132,30731 legs · 546,474 sh · $18,868,35083
HERON THERAPEUTICS, INC. /DE/ (HRTX)Director4——7
ALIMERA SCIENCES INC (ALIM)Director3——4

Insider filings — Kaseta Michael

FiledFormIssuerReported transactionsSource
2026-10-134Liquidia Corp (LQDA)Option exercise (M): 5,828 · Option exercise (M): 7,049 · Sale (S): 18,938 @ $28.48 · Option exercise (M): 5,828 (derivative) @ $0 · Option exercise (M): 7,049 (derivative) @ $0EDGAR
2026-07-144Liquidia Corp (LQDA)Option exercise (M): 5,829 · Option exercise (M): 7,050 · Sale (S): 1,453 @ $71.39 · Sale (S): 18,977 @ $71.52 · Option exercise (M): 5,829 (derivative) @ $0 · Option exercise (M): 7,050 (derivative) @ $0EDGAR
2026-04-164Liquidia Corp (LQDA)Option exercise (M): 3,000 @ $2.79 · Sale (S): 3,000 @ $40 · Sale (S): 9,044 @ $40.14 · Option exercise (M): 86,971 @ $2.79 · Sale (S): 86,971 @ $40.14 · Sale (S): 43,375 @ $40.14 · +2 moreEDGAR
2026-04-144Liquidia Corp (LQDA)Option exercise (M): 23,821 @ $2.79 · Sale (S): 23,821 @ $40.14 · Option exercise (M): 5,828 · Option exercise (M): 7,050 · Sale (S): 18,958 @ $38.37 · Option exercise (M): 23,821 (derivative) @ $0 · +2 moreEDGAR
2026-04-134Liquidia Corp (LQDA)Option exercise (M): 19,042 @ $2.79 · Option exercise (M): 86,632 @ $2.79 · Option exercise (M): 18,115 @ $2.97 · Option exercise (M): 728 @ $2.54 · Option exercise (M): 9,272 @ $2.54 · Sale (S): 133,789 @ $40.24 · +5 moreEDGAR
2026-03-034Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,165 @ $30.58 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2026-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 53,960 @ $0EDGAR
2026-01-214Liquidia Corp (LQDA)Grant/award (A): 59,320 @ $0 · Grant/award (A): 88,980 (derivative) @ $0EDGAR
2026-01-134Liquidia Corp (LQDA)Option exercise (M): 5,828 · Option exercise (M): 28,200 · Sale (S): 36,932 @ $37.43 · Option exercise (M): 5,828 (derivative) @ $0 · Option exercise (M): 28,200 (derivative) @ $0EDGAR
2025-12-024Liquidia Corp (LQDA)Option exercise (M): 2,343 · Sale (S): 1,166 @ $32.19 · Option exercise (M): 2,343 (derivative) @ $0EDGAR
2025-10-154Liquidia Corp (LQDA)Option exercise (M): 5,828 · Sale (S): 11,630 @ $23.41 · Option exercise (M): 5,828 (derivative) @ $0EDGAR
2025-09-034Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,148 @ $29.05 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2025-08-194Liquidia Corp (LQDA)Sale (S): 20,000 @ $26.18EDGAR
2025-08-074Liquidia Corp (LQDA)Sale (S): 30,000 @ $20.00EDGAR
2025-07-154Liquidia Corp (LQDA)Option exercise (M): 5,828 · Sale (S): 11,580 @ $14.28 · Option exercise (M): 5,828 (derivative) @ $0EDGAR
2025-06-054Liquidia Corp (LQDA)Option exercise (M): 29,141 · Sale (S): 14,777 @ $16.97 · Option exercise (M): 29,141 (derivative) @ $0EDGAR
2025-06-034Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 859 @ $16.74 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2025-04-164Liquidia Corp (LQDA)Sale (S): 8,283 @ $13.57EDGAR
2025-03-044Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 874 @ $15.45 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2025-02-044/AHERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0EDGAR
2025-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73EDGAR
2025-01-144Liquidia Corp (LQDA)Grant/award (A): 112,797 @ $0 · Sale (S): 23,370 @ $11.78 · Grant/award (A): 112,797 (derivative) @ $0EDGAR
2024-12-034Liquidia Corp (LQDA)Option exercise (M): 2,343 · Sale (S): 1,091 @ $11.51 · Option exercise (M): 2,343 (derivative) @ $0EDGAR
2024-11-064HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 37,879 · Grant/award (A): 227,272 (derivative) @ $1.78EDGAR
2024-10-154Liquidia Corp (LQDA)Sale (S): 3,892 @ $11.11EDGAR
2024-09-184ALIMERA SCIENCES INC (ALIM)Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 1,825 (derivative)EDGAR
2024-09-044Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,079 @ $9.50 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2024-07-154Liquidia Corp (LQDA)Sale (S): 3,906 @ $12.53EDGAR
2024-06-044Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 1,094 @ $14.55 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2024-04-164Liquidia Corp (LQDA)Sale (S): 3,136 @ $14.58EDGAR
2024-03-194Liquidia Corp (LQDA)Option exercise (M): 2,344 · Sale (S): 851 @ $15.82 · Sale (S): 11,315 @ $15.82 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2024-01-164Liquidia Corp (LQDA)Grant/award (A): 93,250 @ $0 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 93,250 (derivative) @ $0EDGAR
2023-12-054Liquidia Corp (LQDA)Option exercise (M): 2,343 · Option exercise (M): 2,343 (derivative) @ $0EDGAR
2023-10-044ALIMERA SCIENCES INC (ALIM)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2023-09-054Liquidia Corp (LQDA)Option exercise (M): 2,344 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2023-06-024Liquidia Corp (LQDA)Option exercise (M): 2,344 · Option exercise (M): 2,344 (derivative) @ $0EDGAR
2023-04-104/ALiquidia Corp (LQDA)Grant/award (A): 1,927 @ $4.90EDGAR
2023-03-284ALIMERA SCIENCES INC (ALIM)Grant/award (A): 1,825 (derivative) @ $0EDGAR
2023-03-024Liquidia Corp (LQDA)Option exercise (M): 9,375 · Option exercise (M): 9,375 (derivative) @ $0EDGAR
2023-01-134Liquidia Corp (LQDA)Grant/award (A): 124,667 @ $0 · Grant/award (A): 159,829 (derivative) @ $0EDGAR
2022-09-144Liquidia Corp (LQDA)Purchase (P): 8,000 @ $5.99EDGAR
2022-09-014Liquidia Corp (LQDA)Purchase (P): 1,927 @ $4.90EDGAR
2022-08-014Liquidia Corp (LQDA)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2022-06-014Liquidia Corp (LQDA)Purchase (P): 13,639 @ $4.01 · Purchase (P): 5,061 @ $4EDGAR
2022-01-194Liquidia Corp (LQDA)Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2021-11-124Liquidia Corp (LQDA)Option exercise (M): 9,250 · Grant/award (A): 9,250 (derivative) @ $0EDGAR
2021-07-234Liquidia Corp (LQDA)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-01-204Liquidia Corp (LQDA)Grant/award (A): 18,500 (derivative) @ $0 · Grant/award (A): 9,250 (derivative) @ $0EDGAR
2020-12-014Liquidia Corp (LQDA)Grant/award (A): 230,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724346 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs